• Exchange: Munich
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Ark Therapeutics Group PLC

+ Add to Watchlist

TXF:GR

Trading has been suspended for TXF:GR

Snapshot for Ark Therapeutics Group PLC (TXF)

Open: - Day's Range: - Volume: 0
Previous Close: 0.006 52wk Range: - 1-Yr Rtn: -

Stock Chart for TXF

No chart data available.
  • TXF:GR 0.006
  • 1M
  • 1Y
0.006
Interactive TXF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TXF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (GBP) (ttm) -
Est. EPS (GBP) (12/2014) -
Est. PEG Ratio -
Market Cap (M EUR) 0.00
Shares Outstanding (M) 209.28
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TXF

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for TXF

Ark Therapeutics Group PLC develops medicinal gene-based and biological therapies and diagnostic products. The Company develops products to treat vascular disease and cancer.

Sue StevenSecretary
More Company Profile & Key Executives for TXF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil